ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Rheumatology

Top Rheumatology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID ROSENBERG M.D.

Rheumatology

15,835

$1.11M

463
322 are 65+

19%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $108

MARK BOX MD

Rheumatology

15,183

$1.75M

717
403 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

22%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $108

MICHAEL JOSEPH MD

Rheumatology

14,081

$956K

816
632 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $108

SANDRA HOFFMANN M.D.

Rheumatology

12,846

$1.32M

666
406 are 65+

20%
patients receiving schedule two controlled substances

Avg: 4%

24%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $108

KAREN RICE M.D.

Rheumatology

10,975

$1.18M

417
266 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $108

JOSEPH MAYUS MD

Rheumatology

10,210

$849K

573
327 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

30%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $108

JAMES ESTHER M.D.

Rheumatology

8,827

$752K

699
632 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

14%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$85
Average prescription price

Avg: $108

RICHARD DIVALERIO M.D.

Rheumatology

8,030

$743K

510
397 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $108

STEVEN BAAK M.D.

Rheumatology

8,001

$665K

555
337 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $108

ROBERT JACKSON D.O.

Rheumatology

7,540

$957K

642
396 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$127
Average prescription price

Avg: $108

STEPHEN ARMSTRONG MD

Rheumatology

7,003

$539K

472
285 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

27%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $108

DAVID TRUE D.O.

Rheumatology

6,783

$878K

507
331 are 65+

13%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $108

ROBERT SCHNEIDER MD

Rheumatology

6,744

$477K

388
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

5%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $108

NORMAN SIMON MD

Rheumatology

6,538

$746K

546
382 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

16%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $108

ANNE WINKLER MD

Rheumatology

6,510

$746K

586
402 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

10%
patients receiving schedule three controlled substances

Avg: 10%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$115
Average prescription price

Avg: $108

FRANCISCO GARRIGA M.D.

Rheumatology

5,963

$384K

443
309 are 65+

8%
patients receiving schedule two controlled substances

Avg: 4%

15%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$64
Average prescription price

Avg: $108

KENT HUSTON M.D.

Rheumatology

5,953

$513K

712
548 are 65+

2%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$86
Average prescription price

Avg: $108

KEITH BERNSTEIN MD

Rheumatology

5,854

$324K

382
331 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $108

JOHN BUDD MD

Rheumatology

5,569

$386K

480
367 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

18%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $108

WILLIAM IRVIN M.D.

Rheumatology

5,540

$634K

273
213 are 65+

11%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $108

SHERRY SHUMAN

Rheumatology

5,252

$636K

307
229 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $108

KONGSAK TANPHAICHITR M.D.

Rheumatology

5,056

$258K

204
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

26%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $108

MARK JAREK MD

Rheumatology

5,046

$820K

398
257 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$162
Average prescription price

Avg: $108

IRL DON MD

Rheumatology

4,795

$275K

345
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

4%
patients receiving schedule three controlled substances

Avg: 10%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $108

HAMID BASHIR MD

Rheumatology

4,494

$549K

485
253 are 65+

4%
patients receiving schedule two controlled substances

Avg: 4%

25%
patients receiving schedule three controlled substances

Avg: 10%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $108

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank